摘要:
Novel compounds represented by general formula (I), stereoisomers thereof, pharmaceutically acceptable salts, and solvates thereof, processes for the preparation thereof, a matrix metalloproteinase inhibitor comprising as the active ingredient at least one member selected among the above compounds, intermediates for preparing the compounds represented by general formula (I), and a process for preparing the same.